Evidence map›Paper›PMID 35282679›Full record

ArticleJournal of the American Chemical Society2022

Selective Recognition of Carbohydrate Antigens by Germline Antibodies Isolated from AID Knockout Mice.

Andrew T DeLaitsch, Jacey R Pridgen, Avery Tytla, Megan L Peach, Rayleen Hu, David W Farnsworth, Aislinn K McMillan, Natalie Flanagan, J Sebastian Temme, Marc C Nicklaus and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Andrew T DeLaitschChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States.ORCID 0000-0002-3458-3449
Jacey R PridgenChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States.
Avery TytlaChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States.
Megan L PeachBasic Science Program, Chemical Biology Laboratory, Leidos Biomedical Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States.
Rayleen HuChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States.
David W FarnsworthChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States.
Aislinn K McMillanChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States.ORCID 0000-0002-7343-9693
Natalie FlanaganChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States.
J Sebastian TemmeChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States.
Marc C NicklausChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States.
Jeffrey C GildersleeveChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States.ORCID 0000-0002-3744-6423
Frederick National Laboratory for Cancer Research · USLeidos (United States) · US

Funding

Structural Basis of Immune Recognition of Glycosylated AntigensU54GM062116 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI ALVAREZ, RICHARD · 2001 to 2010
$80.3M
Carbohydrate Microarray Profiling of Glycan-Binding Antibodies and LectinsZIABC010740 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI GILDERSLEEVE, JEFFREY · 2009 to 2025
$10.7M
Serum Antibody Profiling with a Carbohydrate MicroarrayZIABC011055 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI GILDERSLEEVE, JEFFREY · 2009 to 2025
$6.3M
Synthetically Accessible Virtual Inventory (SAVI)ZIABC011666 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NICKLAUS, MARC · 2015 to 2025
$4.5M
In Silico Screening for Cancer TargetsZICBC010639 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NICKLAUS, MARC · 2009 to 2024
$4.2M
Large Databases of Small Molecules - Drug Development Tool and Public ResourceZICBC010517 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NICKLAUS, MARC · 2009 to 2025
$3.7M
HIV Integrase Modeling and Computer-Aided Inhibitor DevelopmentZIABC010524 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NICKLAUS, MARC · 2009 to 2024
$2.6M
Better Understanding and Handling of TautomerismZIABC011785 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NICKLAUS, MARC · 2017 to 2025
$2.0M
Fundamentals of Ligand-Protein InteractionsZIABC010832 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NICKLAUS, MARC · 2009 to 2024
$1.7M
CCR NIH HHS HHSN261200800001CIntramural NIH HHS ZIA BC011055NCI NIH HHS HHSN261200800001ENIGMS NIH HHS U54 GM062116
6 · The paper itself

Abstract

Germline antibodies, the initial set of antibodies produced by the immune system, are critical for host defense, and information about their binding properties can be useful for designing vaccines, understanding the origins of autoantibodies, and developing monoclonal antibodies. Numerous studies have found that germline antibodies are polyreactive with malleable, flexible binding pockets. While insightful, it remains unclear how broadly this model applies, as there are many families of antibodies that have not yet been studied. In addition, the methods used to obtain germline antibodies typically rely on assumptions and do not work well for many antibodies. Herein, we present a distinct approach for isolating germline antibodies that involves immunizing activation-induced cytidine deaminase (AID) knockout mice. This strategy amplifies antigen-specific B cells, but somatic hypermutation does not occur because AID is absent. Using synthetic haptens, glycoproteins, and whole cells, we obtained germline antibodies to an assortment of clinically important tumor-associated carbohydrate antigens, including Lewis Y, the Tn antigen, sialyl Lewis C, and Lewis X (CD15/SSEA-1). Through glycan microarray profiling and cell binding, we demonstrate that all but one of these germline antibodies had high selectivity for their glycan targets. Using molecular dynamics simulations, we provide insights into the structural basis of glycan recognition. The results have important implications for designing carbohydrate-based vaccines, developing anti-glycan monoclonal antibodies, and understanding antibody evolution within the immune system.

Indexed as

Antibodies, MonoclonalAntigens, Tumor-Associated, CarbohydrateAnimalsBiomarkers, TumorCarbohydratesGerm CellsMiceMice, KnockoutPolysaccharidesAntibodies, MonoclonalAntigens, Tumor-Associated, CarbohydrateBiomarkers, TumorCarbohydratesPolysaccharides

Identifiers

PMID35282679
PMCPMC10506689
OpenAlexW4220733137

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.